(Q39926773)

English

Prediction of drug-related cardiac adverse effects in humans--A: creation of a database of effects and identification of factors affecting their occurrence

scientific article published on 22 November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Prediction of drug-related cardiac adverse effects in humans--A: creation of a database of effects and identification of factors affecting their occurrence (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

0 references

author name string

Edwin J Matthews

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Anna A Frid

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

0 references

publication date

22 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Regulatory Toxicology and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

247-275

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.006

7 January 2021

Describing the validity of carcinogen screening tests

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.006

7 January 2021

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.006

7 January 2021

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.006

7 January 2021

Prediction of drug-related cardiac adverse effects in humans--B: use of QSAR programs for early detection of drug-induced cardiac toxicities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.006

7 January 2021

Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.006

7 January 2021

A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.006

7 January 2021

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.006

7 January 2021

In silico approaches to explore toxicity end points: issues and concerns for estimating human health effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.006

7 January 2021

Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part C: use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.006

7 January 2021

Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.006

7 January 2021

The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.006

7 January 2021

Emetine inhibits glycolysis in isolated, perfused rat hearts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.006

7 January 2021

Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.11.006

7 January 2021

Identifiers

10.1016/J.YRTPH.2009.11.006

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39926773&oldid=1878707224"